Target intelligence / Profile preview

Family with sequence similarity 216 member A (FAM216A)

Target
FAM216A
Molecular classification
Other (uncharacterized protein)
01

Overview

Family with sequence similarity 216 member A (FAM216A) is a protein encoded by the human FAM216A gene (also known as C12orf24), located at chromosome 12q24.11[1][3]. It is predicted to be an intracellular, predominantly nuclear, protein of 273 amino acids with no well-characterized domains or established molecular function[1][3]. FAM216A is mainly expressed in the testis (especially Sertoli cells) and in the brain, with lower expression in many other tissues[1][4]. No biochemical activity, signaling function, or direct disease mechanism has been established. The protein is uncharacterized, not recognized as a receptor, enzyme, transporter, or therapeutic target. Some protein-protein interactions have been computationally predicted with factors involved in cell cycle and apoptosis (e.g., MAGEA10, DKC1)[1], but these require experimental validation. Disease associations with hematologic cancers and carboxypeptidase N deficiency have been reported based on genetic studies, but the causal or mechanistic relationships remain unknown[3]. There are no drugs or known mechanisms of drug action targeting FAM216A. FAM216A is not considered a therapeutic target based on current evidence.

Other names
FAM216AC12orf24HSU79274protein FAM216Auncharacterized protein C12orf24protein predicted by clone 23733
02

Biological functions

Other (function unknown)
03

Disease associations

Cancer (reported association with hematologic cancer)Other (carboxypeptidase N deficiency with unclear mechanistic link)

Beyond the preview

Go deeper on Family with sequence similarity 216 member A (FAM216A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 216 member A (FAM216A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call